Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis: results from a phase 2, randomised, double-blind, double-dummy study
用户EMtIfkjv0BaE
4小时前
13
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-08-15 12:35:03 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2468-1253(25)00128-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2468125325001281
其他信息:
出版社: Elsevier BV
作者: Vincent Wai-Sun Wong; Neeta B Amin; Hirokazu Takahashi; Amanda Darekar; Frank Tacke; Jan Kiszko; Hector Rodriguez; Atsushi Nakajima; Naim Alkhouri; Michael Charlton; Quentin M Anstee
